Skip to main content

A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam

Psychopharmacology volume 204, pages 113–125 (2009)Cite this article

Abstract

Rationale

Preclinical models are needed to investigate the neurobiology and psychobiology of binge eating and to identify innovative pharmacotherapeutic strategies.

Objectives

A modification of the model based on the combination of cyclic caloric restrictions and acute stress was developed to further increase its face validity and reliability and, for the first time, to assess its predictive value.

Materials and methods

Four groups of female rats were employed: group 1 was normally fed and not stressed on the test day (25th); group 2 was fed normally but was exposed to an acute stress on day 25; group 3 was exposed to three cycles (4 days 66% of chow intake + 4 days food ad libitum) of yo-yo dieting but not stressed; and group 4 was exposed to cyclic yo-yo dieting and then stressed. All groups were fed highly palatable food (HPF) for 2 h on days 5–6 and 13–14. Acute stress was elicited by exposing rats to HPF, but preventing them from access to it for 15 min.

Results

The combination of cyclic food restriction and stressful exposure to food markedly increased HPF intake. Sibutramine and fluoxetine inhibited food intake in all conditions. Topiramate selectively inhibited compulsive HPF intake in rats submitted to caloric restriction and stress. Midazolam increased HPF intake.

Conclusions

Pharmacological results suggest that this model, in addition to face validity as an isomorphic model of human binge eating, is endowed with good predictive validity.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  • Abraham SF, Beumont PJV (1982) How patients describe bulimia or binge eating. Psychol Med 12:625–635

    PubMed  CAS  Article  Google Scholar 

  • Akana SF, Cascio CS, Du J-Z, Levin N, Dallman MF (1986) Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotrpin to inhibition of corticosterone in the morning and evening. Endocrinology 119:2325–2332

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (2000) Diagnostic and statistic manual of mental disorders, IV-TR. APA, Washington, DC

    Google Scholar 

  • Appolinario JC, Godoy-Matos A, Fontenelle LF, Carraro L, Cabral M, Vieira A, Coutinho W (2002) An open-label trial of sibutramine in obese patients with binge-eating disorder. J Clin Psychiatry 63:28–30

    PubMed  CAS  Google Scholar 

  • Appolinario JC, McElroy SL (2004) Pharmacological approaches in the treatment of binge eating disorders. Curr Drug Targets 5:301–307

    PubMed  Article  CAS  Google Scholar 

  • Arnold LM, McElroy SL, Hudson JI, Welge JA, Bennett AJ, Keck PE (2002) A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder. J Clin Psychiatry 63:1028–1033

    PubMed  CAS  Google Scholar 

  • Artiga AI, Viana JB, Maldonado CR, Chandler-Laney PC, Oswald KD, Boggiano MM (2007) Body composition and endocrine status of long-term stress-induced binge-eating rats. Physiol Behav 91:424–431

    PubMed  Article  CAS  Google Scholar 

  • Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG Jr (2003) Pharmacologic treatment of binge eating disorder. Int J Eat Disord 34(suppl):S74–S88

    PubMed  Article  Google Scholar 

  • Cooper SJ (2005) Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtype. Appetite 44:133–150

    PubMed  Article  CAS  Google Scholar 

  • Cooper SJ, Estall LB (1985) Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors. Neurosci Biobehav Rev 9:5–19

    PubMed  Article  CAS  Google Scholar 

  • Corwin RL, Buda-Levin A (2004) Behavioral models of binge-type eating. Physiol Behav 82:123–130

    PubMed  Article  CAS  Google Scholar 

  • Crowther JH, Sanftner J, Bonifazi DZ, Shepherd KL (2001) The role of daily hassles in binge eating. Int J Eat Disord 29:449–454

    PubMed  Article  CAS  Google Scholar 

  • De Bernardi C, Ferraris S, D’Innella P, Do F, Torre E (2005) Topiramate for binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 29:339–341

    PubMed  Article  CAS  Google Scholar 

  • Dolengevich Segal H, Rodriguez Salgado B, Conejo Garcia A, San Sebastian Cabases J (2006) Efficacy of topiramate in children and adolescent with problems of impulse control: preliminary results. Actas Esp Psiquiatr 34:280–282

    PubMed  CAS  Google Scholar 

  • Freeman LM, Gil KM (2004) Daily stress, coping, and dietary restraint in binge eating. Int J Eat Disord 36:204–212

    PubMed  Article  Google Scholar 

  • Hagan MM, Moss DE (1997) Persistence of binge-eating patterns after a history of restriction with intermittent bouts of refeeding on palatable food in rats: implications for bulimia nervosa. Int J Eat Disord 22:411–420

    PubMed  Article  CAS  Google Scholar 

  • Hagan MM, Wauford PK, Chandler PC, Jarrett LA, Rybak RJ, Blackburn K (2002) A new animal model of binge-eating: key synergistic role of past caloric restriction and stress. Physiol Behav 77:45–54

    PubMed  Article  CAS  Google Scholar 

  • Hagan MM, Chandler PC, Wauford PK, Rybak RJ, Oswald KD (2003) The role of palatable food and hunger as trigger factors in an animal model of stress-induced binge-eating. Int J Eat Disord 34:183–197

    PubMed  Article  Google Scholar 

  • Han DH, Lyool IK, Sung YH, Lee SH, Renshaw PF (2008) The effect of acamprosate on alcohol and food craving in patients with alcohol dependence. Drug Alcohol Depend 93:279–283

    PubMed  Article  CAS  Google Scholar 

  • Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103:15236–15241

    PubMed  Article  CAS  Google Scholar 

  • Hudson JI, Hiripi E, Pope HG Jr., Kessler RC (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61:348–358

    PubMed  Article  Google Scholar 

  • Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ (1997) Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 121:1758–1762

    PubMed  Article  CAS  Google Scholar 

  • Johannessen Landmark C (2007) Targets for antiepileptic drugs in the synase. Med Sci Monit 13:RA1–RA7

    Google Scholar 

  • Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K et al (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677–1685

    PubMed  Article  CAS  Google Scholar 

  • Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O’Brien CP (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75:233–240

    PubMed  Article  CAS  Google Scholar 

  • Kjelsas E, Bjornstrom C, Gotestam KG (2004) Prevalence of eating disorders in female and male adolescents (14–15 years). Eat Behav 5:13–25

    PubMed  Article  Google Scholar 

  • LeBlanc M, Thibault L (2003) Effect of sibutramine on macronutrient selection in male and female rats. Physiol Behav 80:243–252

    PubMed  Article  CAS  Google Scholar 

  • Leigh AJ, Stock MJ, Lacey JH, Wilson CA (1998) Diet-induced loss of cyclic ovarian function at normal body weight in a rodent model for bulimia nervosa. J Reprod Fertil 112:217–223

    PubMed  CAS  Article  Google Scholar 

  • Leombruni P, Pierò A, Lavagnino L, Brustolin A, Campisi S, Fassino S (2008) A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorder. Progr Neuropsychopharmacol Biol Psychiatry 32:1599–1605

    Article  CAS  Google Scholar 

  • Martin-Fardon R, Ciccocioppo R, Massi M, Weiss F (2000) Nociceptin/orphanin FQ prevents stress induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport 11:1939–1943

    PubMed  Article  CAS  Google Scholar 

  • McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC et al (2004) Topiramate in the long-term treatment of binge eating disorder associated with obesity. J Clin Psychiatry 65:1453–1469

    Google Scholar 

  • McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR et al (2007) Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61:1039–1048

    PubMed  Article  CAS  Google Scholar 

  • Milano W, Petrella C, Casella A, Capasso A, Carrino S, Milano L (2005) Use of sibutramine, an inhibitor of the reuptake or serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study. Adv Ther 22:25–31

    PubMed  Article  CAS  Google Scholar 

  • National Institute for Clinical Excellence (2004) Eating disorders—core interventions in the treatment and management of anorexia nervosa, bulimia nervosa, and related eating disorders. National Institute for Clinical Excellence, London

    Google Scholar 

  • Padwal RS, Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine and rimonabant. Lancet 369:71–77

    PubMed  Article  CAS  Google Scholar 

  • Polivy J, Zeitlin SB, Herman CP, Beal AL (1994) Food restriction and binge eating: a study of former prisoner of war. J Abnorm Psychol 103:409–411

    PubMed  Article  CAS  Google Scholar 

  • Reid MS, Palamar J, Raghavan S, Flammino F (2007) Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers. Psychopharmacology (Berl) 192:147–158

    Article  CAS  Google Scholar 

  • Resis AD, Castro LA, Faria R, Laranjeira R (2008) Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. Rev Bras Psiquiatr 30:132–135

    Google Scholar 

  • Robbins TW, Fray PJ (1980) Stress-induced eating: fact, fiction or misunderstanding. Appetite 1:103–133

    Google Scholar 

  • Schneiderman JH (1998) Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci 25:S3–S5

    PubMed  CAS  Google Scholar 

  • Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM (2007) Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 40:321–336

    PubMed  Article  Google Scholar 

  • Simeone TA, Wilcox KS, White HS (2006) Subunit selectivity of topiramate modulation of heteromeric GABA(A) receptors. Neuropharmacology 50:845–857

    PubMed  Article  CAS  Google Scholar 

  • Smith GP (1989) Animal models of human eating disorders. Ann N Y Acad Sci 575:63–72

    PubMed  Article  CAS  Google Scholar 

  • Spitzer RL, Stunkard A, Yanovski S, Marcus MD, Wadden T, Wing R, Mitchell J, Hasin D (1993) Binge eating disorder should be included in DSM-IV: a reply to Fairburn et al.’s “the classification of recurrent overeating: the binge eating disorder proposal”. Int J Eat Disord 13:161–169

    PubMed  Article  CAS  Google Scholar 

  • Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL (1993a) Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 13:137–153

    PubMed  Article  CAS  Google Scholar 

  • Sterritt GM (1962) Inhibition and facilitation of eating by electric shock. J Comp Physiol Psychol 55:226–229

    PubMed  Article  CAS  Google Scholar 

  • Stice E, Agras WS, Telch FC, Halmi KA, Mitchell JE, Wilson T (2001) Subtyping binge eating-disordered women along dieting and negative affect dimensions. Int J Eat Disord 30:11–27

    PubMed  Article  CAS  Google Scholar 

  • Vitale G, Arletti R, Ruggieri V, Cifani C, Massi M (2006) Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats. Peptides 27:2193–2200

    PubMed  Article  CAS  Google Scholar 

  • Wardle J, Steptoe A, Oliver G, Lipsey Z (2000) Stress, dietary restraint and food intake. J Psychosom Res 48:195–202

    PubMed  Article  CAS  Google Scholar 

  • Waters A, Hill A, Waller G (2001) Internal and external antecedents of binge eating episodes in a group of women with bulimia nervosa. Int J Eat Disord 29:17–22

    PubMed  Article  CAS  Google Scholar 

  • Weltzin TE, Hsu LKG, Pollice C, Kaye WH (1991) Feeding pattern in bulimia nervosa. Biol Psychiatry 30:1093–1110

    PubMed  Article  CAS  Google Scholar 

  • White HS, Smith MD, Wilcox KS (2007) Mechanism of action of antiepileptic drugs. Int Rev Neurobiol 81:85–110

    PubMed  Article  CAS  Google Scholar 

  • Wilfley DE, Crow SJ, Hudson JI, Mitchell JE, Berkowitz RI, Blakesley V, Walsh BT (2008) Sibutramine eating disorder research Group. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry 165:51–58

    PubMed  Article  Google Scholar 

  • Willner P (1991) Behavioural models in psychopharmacology. In: Willner P (ed) Behavioural models in psychopharmacology. Cambridge University Press, Cambridge, pp 3–18

    Google Scholar 

  • Wolff GE, Crosby RD, Roberts JA, Wittrock DA (2000) Differences in daily stress, mood, coping, and eating behavior in binge eating and nonbinge eating college women. Addict Behav 25:205–16

    PubMed  Article  CAS  Google Scholar 

  • Yanovski SZ (1993) Binge eating disorder: current knowledge and future directions. Obes Res 1:4163–4169

    Google Scholar 

Download references

Acknowledgements

This study was supported by the MURST, Rome, Italy (PRIN 2006 to M. Massi).

Author information

Authors and Affiliations

  1. Department of Experimental Medicine and Public Health, University of Camerino, Via Madonna delle Carceri, 62032, Camerino, Italy

    Carlo Cifani, Carlo Polidori, Sergio Melotto, Roberto Ciccocioppo & Maurizio Massi

Authors
  1. Carlo Cifani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlo Polidori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sergio Melotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roberto Ciccocioppo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maurizio Massi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maurizio Massi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Cifani, C., Polidori, C., Melotto, S. et al. A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam. Psychopharmacology 204, 113–125 (2009). https://doi.org/10.1007/s00213-008-1442-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-008-1442-y

Keywords

  • Binge eating
  • Caloric restriction
  • Environmental stress
  • Palatable food
  • Sibutramine
  • Fluoxetine
  • Topiramate
  • Midazolam
  • Female rats